BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10575648)

  • 1. Pharmacogenetics of cytochromes P450.
    Hasler JA
    Mol Aspects Med; 1999; 20(1-2):12-24, 25-137. PubMed ID: 10575648
    [No Abstract]   [Full Text] [Related]  

  • 2. [Genetic polymorphism of drug metabolizing enzymes].
    Yokoi T; Kamataki T
    Seikagaku; 1997 Oct; 69(10):1196-9. PubMed ID: 9431010
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population.
    Bozina N; Granić P; Lalić Z; Tramisak I; Lovrić M; Stavljenić-Rukavina A
    Croat Med J; 2003 Aug; 44(4):425-8. PubMed ID: 12950145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics: role in modifying drug dosage regimens.
    Mah JT; Wong JY; Lee EJ
    Ann Acad Med Singap; 2000 Sep; 29(5):628-32. PubMed ID: 11126699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics and psychopharmacotherapy.
    Poolsup N; Li Wan Po A; Knight TL
    J Clin Pharm Ther; 2000 Jun; 25(3):197-220. PubMed ID: 10886465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Status of pharmacogenomics and its future role in drug therapy].
    Cascorbi I
    Internist (Berl); 2002 Apr; 43(4):506-10. PubMed ID: 12053407
    [No Abstract]   [Full Text] [Related]  

  • 7. Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population.
    Halling J; Petersen MS; Damkier P; Nielsen F; Grandjean P; Weihe P; Lundgren S; Lundblad MS; Brøsen K
    Eur J Clin Pharmacol; 2005 Aug; 61(7):491-7. PubMed ID: 16025294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.
    de Leon J; Susce MT; Murray-Carmichael E
    Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNaPshot for pharmacogenetics by minisequencing.
    Bender K
    Methods Mol Biol; 2005; 297():243-52. PubMed ID: 15570112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.
    Scordo MG; Caputi AP; D'Arrigo C; Fava G; Spina E
    Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotyping of drug metabolism in infants and children: potentials and problems.
    Rane A
    Pediatrics; 1999 Sep; 104(3 Pt 2):640-3. PubMed ID: 10469807
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of the CYP2D6 and CYP2C19 genotypes on venlafaxine pharmacokinetics in a Japanese population.
    Fukuda T; Nishida Y; Zhou Q; Yamamoto I; Kondo S; Azuma J
    Eur J Clin Pharmacol; 2000 May; 56(2):175-80. PubMed ID: 10877013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic polymorphisms of drug metabolizing enzymes].
    Fujieda M; Yamazaki H; Kamataki T
    Gan To Kagaku Ryoho; 2002 May; 29(5):663-8. PubMed ID: 12040668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphism of CYP2D6 and CYP2C19 in east- and southern African populations including psychiatric patients.
    Dandara C; Masimirembwa CM; Magimba A; Sayi J; Kaaya S; Sommers DK; Snyman JR; Hasler JA
    Eur J Clin Pharmacol; 2001 Apr; 57(1):11-7. PubMed ID: 11372584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacogenetics].
    Hach I; Kirch W
    Praxis (Bern 1994); 2008 Oct; 97(21):1127-9. PubMed ID: 18951351
    [No Abstract]   [Full Text] [Related]  

  • 16. Populations and genetic polymorphisms.
    Weber WW
    Mol Diagn; 1999 Dec; 4(4):299-307. PubMed ID: 10671640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages.
    Kirchheiner J; Brøsen K; Dahl ML; Gram LF; Kasper S; Roots I; Sjöqvist F; Spina E; Brockmöller J
    Acta Psychiatr Scand; 2001 Sep; 104(3):173-92. PubMed ID: 11531654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline pharmacogenetics of tamoxifen response: have we learned enough?
    Desta Z; Flockhart DA
    J Clin Oncol; 2007 Nov; 25(33):5147-9. PubMed ID: 18024859
    [No Abstract]   [Full Text] [Related]  

  • 19. [Individualization of drug therapy and pharmacogenetics].
    Yamamoto I; Azuma J
    Nihon Rinsho; 1998 Mar; 56(3):579-83. PubMed ID: 9549339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in the study of pharmacogenetics in China in 1996].
    Xie H; Zhou H
    Zhonghua Yi Xue Za Zhi; 1997 Jan; 77(1):77-8. PubMed ID: 9596985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.